Bioextrax AB (publ) (STO:BIOEX)

Market Cap	119.48M -17.6%
Revenue (ttm)	1.33M +39.7%
Net Income	-18.05M
EPS	-0.44
Shares Out	47.60M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	67,077
Open	2.550
Previous Close	2.540
Day's Range	2.420 - 2.600
52-Week Range	1.600 - 4.000
Beta	1.49
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 19, 2026

About Bioextrax AB

Bioextrax AB (publ) develops and commercializes a bio-based extraction platform technology. The company produces PHA (polyhydroxyalkanoates), a group of bio-based and biodegradable bioplastics that replace fossil-based plastics; PHBV, a stiff, high-performance polymer; and PHO, a soft, flexible, and smooth biopolymer with rubbery properties. It also provides hydrolysates protein for animal feed; and keratin microfibers provides insulation, additive and barrier properties for composites, agriculture, filtration, padding, textiles, and more. Bioe...

• Industry: Waste Management
• Sector: Industrials
• Founded: 2014
• Employees: 14
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: BIOEX

Financial Performance

In 2025, Bioextrax AB's revenue was 1.24 million, an increase of 22.55% compared to the previous year's 1.01 million. Losses were -17.71 million, 2.12% more than in 2024.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Aug 12, 2026

Data Sources Report a data error